World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
57215
World Ranking
4311
National Ranking
425

Overview

Nicholas C.P. Cross is an academic affiliated with the University of Southampton in the United Kingdom. Their research primarily focuses on the field of Medicine, with particular expertise in Hematology, Genetics, Rheumatology, Molecular Biology, and Immunology.

Their main research topics include:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • Eosinophilic Disorders and Syndromes
  • Chronic Lymphocytic Leukemia Research
  • Mast cells and histamine
  • Cancer Genomics and Diagnostics

Regarding their recent publications, these include:

  • "The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms," 2022, published in Leukemia
  • "Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking," 2020, published in Leukemia
  • "European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia," 2023, published in Leukemia
  • "HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions," 2021, published in Leukemia
  • "Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease," 2021, published in Leukemia

Throughout their career, Nicholas C.P. Cross has co-authored multiple scientific papers with frequent collaborators including:

  • Andreas Reiter
  • Andreas Hochhaus
  • Nicole Naumann
  • Alice Fabarius
  • Georgia Metzgeroth

Their work has been published extensively in several scientific journals, with notable publication counts in:

  • Leukemia (17 articles)
  • Blood (11 articles)
  • British Journal of Haematology (7 articles)
  • Clinical Lymphoma Myeloma & Leukemia (4 articles)
  • Blood Advances (3 articles)

The research of Nicholas C.P. Cross contributes to understanding hematological malignancies, with frequent emphasis on leukemia and other blood disorders, as illustrated by their selection of research venues and topics.

Best Publications

  • A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

    Jan Cools;Jan Cools;Daniel J. DeAngelo;Jason Gotlib;Elizabeth H. Stover

  • Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2

    J. Nangalia;C.E. Massie;E.J. Baxter;F.L. Nice

  • Clinical and biological implications of driver mutations in myelodysplastic syndromes.

    Elli Papaemmanuil;Moritz Gerstung;Luca Malcovati;Sudhir Tauro

  • Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

    E. Papaemmanuil;M. Cazzola;J. Boultwood;L. Malcovati

  • Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

    Thomas Ernst;Andrew J Chase;Andrew J Chase;Joannah Score;Joannah Score;Claire E Hidalgo-Curtis;Claire E Hidalgo-Curtis

  • Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy.

    A. Hochhaus;S. Kreil;A. S. Corbin;P. La Rosée;P. La Rosée

  • Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

    Amy V. Jones;Sebastian Kreil;Katerina Zoi;Katherine Waghorn

  • Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

    Timothy P Hughes;Michael W Deininger;Andreas Hochhaus;Susan Branford

  • Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.

    Jane F. Apperley;Martine Gardembas;Junia V. Melo;Robin Russell-Jones

  • Aberrations of EZH2 in cancer

    Andrew Chase;Nicholas C.P. Cross

  • Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

    Raphaël Itzykson;Olivier Kosmider;Aline Renneville;Véronique Gelsi-Boyer

  • Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials

    Susan Branford;Linda Fletcher;Nicholas C.P. Cross;Martin C. Müller

  • Bcr-Abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet

    Simona Soverini;Andreas Hochhaus;Franck E. Nicolini;Franz Gruber

  • JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.

    Amy V Jones;Andrew Chase;Richard T Silver;David Oscier

  • Standardized definitions of molecular response in chronic myeloid leukemia

    N C P Cross;H E White;M C Müller;G Saglio

  • Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation

    Nicholas C.P. Cross;Lin Feng;Andrew Chase;Julie Bungey

  • Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.

    Francis H. Grand;Claire E. Hidalgo-Curtis;Thomas Ernst;Katerina Zoi

  • CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

    Animesh Pardanani;Animesh Pardanani;Animesh Pardanani;Rhett P. Ketterling;Rhett P. Ketterling;Rhett P. Ketterling;Stephanie R. Brockman;Stephanie R. Brockman;Stephanie R. Brockman;Heather C. Flynn;Heather C. Flynn;Heather C. Flynn

  • Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse

    F. Van Rhee;Feng Lin;J. O. Cullis;A. Spencer

  • Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR.

    M. Emig;S. Saussele;H. Wittor;A. Weisser

Frequent Co-Authors

Andreas Reiter
Andreas Reiter Heidelberg University
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
John M. Goldman
John M. Goldman Imperial College London
Torsten Haferlach
Torsten Haferlach MLL Munich Leukemia Laboratory
Richard T. Silver
Richard T. Silver Cornell University
Susanne Schnittger
Susanne Schnittger Ludwig-Maximilians-Universität München
Claudia Haferlach
Claudia Haferlach Ludwig-Maximilians-Universität München
Peter Valent
Peter Valent Medical University of Vienna
Giuseppe Saglio
Giuseppe Saglio University of Turin
Peter J. Campbell
Peter J. Campbell Wellcome Sanger Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related healthcare degrees can open new doors for those interested in medical careers, without the traditional medical school route. Many students consider nursing as a rewarding and flexible pathway. If you already hold a non-nursing degree, online direct entry MSN programs for non-nurses let you transition quickly into advanced nursing roles, leveraging your previous education.

For prospective nurses concerned about admissions, reviewing nursing schools with high acceptance rates can help you find accessible options and reduce the stress of competitive entry requirements. Additionally, some programs provide a more streamlined process—explore a nursing school without teas test to waive standardized entrance exams entirely.

If direct patient care isn’t your preferred route, consider the administrative side of healthcare. Accredited online medical billing and coding programs prepare you for in-demand roles with flexible career options. Check out the best medical billing and coding schools online for recognized training and financial aid opportunities.

These pathways help you find the right fit in healthcare, whether at the bedside, behind the scenes, or advancing your role through further education.

Best Scientists Citing Nicholas C.P. Cross

Trending Scientists

Recently Published Articles